Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.
2.

Repeat HIV testing practices in the era of HIV self-testing among adults in KwaZulu-Natal, South Africa.

Harichund C, Kunene P, Simelane S, Abdool Karim Q, Moshabela M.

PLoS One. 2019 Feb 22;14(2):e0212343. doi: 10.1371/journal.pone.0212343. eCollection 2019.

3.

HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth.

Sheward DJ, Marais J, Bekker V, Murrell B, Eren K, Bhiman JN, Nonyane M, Garrett N, Woodman ZL, Abdool Karim Q, Abdool Karim SS, Morris L, Moore PL, Williamson C.

Cell Host Microbe. 2018 Oct 10;24(4):593-599.e3. doi: 10.1016/j.chom.2018.09.001. Epub 2018 Sep 27.

4.

Acceptability of HIV self-testing among men and women in KwaZulu-Natal, South Africa.

Harichund C, Moshabela M, Kunene P, Abdool Karim Q.

AIDS Care. 2019 Feb;31(2):186-192. doi: 10.1080/09540121.2018.1503638. Epub 2018 Jul 28.

PMID:
30058362
5.

Community-based HIV prevalence in KwaZulu-Natal, South Africa: results of a cross-sectional household survey.

Kharsany ABM, Cawood C, Khanyile D, Lewis L, Grobler A, Puren A, Govender K, George G, Beckett S, Samsunder N, Madurai S, Toledo C, Chipeta Z, Glenshaw M, Hersey S, Abdool Karim Q.

Lancet HIV. 2018 Aug;5(8):e427-e437. doi: 10.1016/S2352-3018(18)30104-8. Epub 2018 Jul 17.

PMID:
30021700
6.

Ex vivo HIV entry into blood CD4+ T cells does not predict heterosexual HIV acquisition in women.

Joag V, Sivro A, Yende-Zuma N, Imam H, Samsunder N, Abdool Karim Q, Abdool Karim S, McKinnon L, Kaul R.

PLoS One. 2018 Jul 9;13(7):e0200359. doi: 10.1371/journal.pone.0200359. eCollection 2018.

7.

Understanding women and men's acceptability of current and new HIV prevention technologies in KwaZulu-Natal, South Africa.

Govender E, Abdool Karim Q.

AIDS Care. 2018 Oct;30(10):1311-1314. doi: 10.1080/09540121.2018.1488027. Epub 2018 Jun 18.

PMID:
29914270
8.

HIV-No time for complacency.

Abdool Karim Q, Abdool Karim SS.

Science. 2018 Jun 15;360(6394):1153. doi: 10.1126/science.aau2663. No abstract available.

PMID:
29903942
9.

Residual T cell activation and skewed CD8+ T cell memory differentiation despite antiretroviral therapy-induced HIV suppression.

Tanko RF, Soares AP, Masson L, Garrett NJ, Samsunder N, Abdool Karim Q, Abdool Karim SS, Riou C, Burgers WA.

Clin Immunol. 2018 Oct;195:127-138. doi: 10.1016/j.clim.2018.06.001. Epub 2018 Jun 5.

PMID:
29883708
10.

'You'll always stay right': understanding vaginal products and the motivations for use among adolescent and young women in rural KZN.

Humphries H, Mehou-Loko C, Phakathi S, Mdladla M, Fynn L, Knight L, Abdool Karim Q.

Cult Health Sex. 2019 Jan;21(1):95-107. doi: 10.1080/13691058.2018.1453086. Epub 2018 Apr 16.

PMID:
29658830
11.

Exploratory analysis of the ecological variables associated with sexual health profiles in high-risk, sexually-active female learners in rural KwaZulu-Natal.

Humphries H, Osman F, Knight L, Abdool Karim Q.

PLoS One. 2018 Apr 5;13(4):e0195107. doi: 10.1371/journal.pone.0195107. eCollection 2018.

12.

Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection.

Laeyendecker O, Konikoff J, Morrison DE, Brookmeyer R, Wang J, Celum C, Morrison CS, Abdool Karim Q, Pettifor AE, Eshleman SH.

J Int AIDS Soc. 2018 Feb;21(2). doi: 10.1002/jia2.25082.

13.

Integrin α4β7 expression on peripheral blood CD4+ T cells predicts HIV acquisition and disease progression outcomes.

Sivro A, Schuetz A, Sheward D, Joag V, Yegorov S, Liebenberg LJ, Yende-Zuma N, Stalker A, Mwatelah RS, Selhorst P, Garrett N, Samsunder N, Balgobin A, Nawaz F, Cicala C, Arthos J, Fauci AS, Anzala AO, Kimani J, Bagaya BS, Kiwanuka N, Williamson C, Kaul R, Passmore JS, Phanuphak N, Ananworanich J, Ansari A, Abdool Karim Q, Abdool Karim SS, McKinnon LR; CAPRISA004 and RV254 study groups.

Sci Transl Med. 2018 Jan 24;10(425). pii: eaam6354. doi: 10.1126/scitranslmed.aam6354.

PMID:
29367348
14.

Serum glycan-binding IgG antibodies in HIV-1 infection and during the development of broadly neutralizing responses.

Scheepers C, Chowdhury S, Wright WS, Campbell CT, Garrett NJ, Abdool Karim Q, Abdool Karim SS, Moore PL, Gildersleeve JC, Morris L.

AIDS. 2017 Oct 23;31(16):2199-2209. doi: 10.1097/QAD.0000000000001643.

15.

High mortality rates in men initiated on anti-retroviral treatment in KwaZulu-Natal, South Africa.

Naidoo K, Hassan-Moosa R, Yende-Zuma N, Govender D, Padayatchi N, Dawood H, Adams RN, Govender A, Chinappa T, Abdool-Karim S, Abdool-Karim Q.

PLoS One. 2017 Sep 13;12(9):e0184124. doi: 10.1371/journal.pone.0184124. eCollection 2017.

16.

Brief Report: Selection of HIV-1 Variants With Higher Transmission Potential by 1% Tenofovir Gel Microbicide.

Ngandu NK, Carlson JM, Chopera DR, Ndabambi N, Abdool Karim Q, Abdool Karim S, Williamson C.

J Acquir Immune Defic Syndr. 2017 Sep 1;76(1):43-47. doi: 10.1097/QAI.0000000000001458.

17.

Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women.

Klatt NR, Cheu R, Birse K, Zevin AS, Perner M, Noël-Romas L, Grobler A, Westmacott G, Xie IY, Butler J, Mansoor L, McKinnon LR, Passmore JS, Abdool Karim Q, Abdool Karim SS, Burgener AD.

Science. 2017 Jun 2;356(6341):938-945. doi: 10.1126/science.aai9383.

PMID:
28572388
18.

Secrecy, empowerment and protection: positioning PrEP in KwaZulu-Natal, South Africa.

Govender E, Mansoor L, MacQueen K, Abdool Karim Q.

Cult Health Sex. 2017 Nov;19(11):1268-1285. doi: 10.1080/13691058.2017.1309682. Epub 2017 Apr 20.

PMID:
28423992
19.

Prevention of HIV in Adolescent Girls and Young Women: Key to an AIDS-Free Generation.

Abdool Karim Q, Baxter C, Birx D.

J Acquir Immune Defic Syndr. 2017 May 1;75 Suppl 1:S17-S26. doi: 10.1097/QAI.0000000000001316. Review.

PMID:
28398993
20.

Genital-Systemic Chemokine Gradients and the Risk of HIV Acquisition in Women.

Liebenberg LJ, Masson L, Arnold KB, Mckinnon LR, Werner L, Proctor E, Archary D, Mansoor LE, Lauffenburger DA, Abdool Karim Q, Abdool Karim SS, Passmore JS.

J Acquir Immune Defic Syndr. 2017 Mar 1;74(3):318-325. doi: 10.1097/QAI.0000000000001218.

21.

Replication Capacity of Viruses from Acute Infection Drives HIV-1 Disease Progression.

Selhorst P, Combrinck C, Ndabambi N, Ismail SD, Abrahams MR, Lacerda M, Samsunder N, Garrett N, Abdool Karim Q, Abdool Karim SS, Williamson C.

J Virol. 2017 Mar 29;91(8). pii: e01806-16. doi: 10.1128/JVI.01806-16. Print 2017 Apr 15.

22.

Effect of Antiretroviral Therapy on the Memory and Activation Profiles of B Cells in HIV-Infected African Women.

Tanko RF, Soares AP, Müller TL, Garrett NJ, Samsunder N, Abdool Karim Q, Abdool Karim SS, Riou C, Burgers WA.

J Immunol. 2017 Feb 1;198(3):1220-1228. doi: 10.4049/jimmunol.1601560. Epub 2016 Dec 30.

23.

The dual burden of gender-based violence and HIV in adolescent girls and young women in South Africa.

Abdool Karim Q, Baxter C.

S Afr Med J. 2016 Dec 1;106(12):1151-1153. doi: 10.7196/SAMJ.2016.v106.i12.12126. No abstract available.

PMID:
27917757
24.

Influences of geo-spatial location on pre-exposure prophylaxis use in South Africa: positioning microbicides for better product uptake.

Govender EM, Mansoor LE, Abdool Karim Q.

AIDS Care. 2017 Jun;29(6):734-740. doi: 10.1080/09540121.2016.1248349. Epub 2016 Nov 1.

PMID:
27799005
25.

Metabolic Syndrome After HIV Acquisition in South African Women.

Sobieszczyk ME, Werner L, Mlisana K, Naicker N, Feinstein A, Gray CM, Masson L, Passmore JS, Williamson C, Abdool Karim Q, Abdool Karim SS, Garrett NJ.

J Acquir Immune Defic Syndr. 2016 Dec 1;73(4):438-445.

PMID:
27391387
26.

Early evolution of human leucocyte antigen-associated escape mutations in variable Gag proteins predicts CD4+ decline in HIV-1 subtype C-infected women.

Chopera DR, Ntale R, Ndabambi N, Garrett N, Gray CM, Matten D, Abdool Karim Q, Abdool Karim S, Williamson C.

AIDS. 2017 Jan 14;31(2):191-197. doi: 10.1097/QAD.0000000000001298.

27.

Cervicovaginal Inflammation Facilitates Acquisition of Less Infectious HIV Variants.

Selhorst P, Masson L, Ismail SD, Samsunder N, Garrett N, Mansoor LE, Abdool Karim Q, Abdool Karim SS, Passmore JS, Williamson C.

Clin Infect Dis. 2017 Jan 1;64(1):79-82. Epub 2016 Sep 29.

28.

Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.

Rademeyer C, Korber B, Seaman MS, Giorgi EE, Thebus R, Robles A, Sheward DJ, Wagh K, Garrity J, Carey BR, Gao H, Greene KM, Tang H, Bandawe GP, Marais JC, Diphoko TE, Hraber P, Tumba N, Moore PL, Gray GE, Kublin J, McElrath MJ, Vermeulen M, Middelkoop K, Bekker LG, Hoelscher M, Maboko L, Makhema J, Robb ML, Abdool Karim S, Abdool Karim Q, Kim JH, Hahn BH, Gao F, Swanstrom R, Morris L, Montefiori DC, Williamson C.

PLoS Pathog. 2016 Jul 19;12(7):e1005742. doi: 10.1371/journal.ppat.1005742. eCollection 2016 Jul. Erratum in: PLoS Pathog. 2017 Sep 25;13(9):e1006641.

29.

Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel.

Archary D, Seaton KE, Passmore JS, Werner L, Deal A, Dunphy LJ, Arnold KB, Yates NL, Lauffenburger DA, Bergin P, Liebenberg LJ, Samsunder N, Mureithi MW, Altfeld M, Garrett N, Abdool Karim Q, Abdool Karim SS, Morris L, Tomaras GD.

Mucosal Immunol. 2016 May;9(3):834. doi: 10.1038/mi.2016.21. No abstract available.

PMID:
27116933
30.

Killer-cell Immunoglobulin-like Receptor (KIR) gene profiles modify HIV disease course, not HIV acquisition in South African women.

Naranbhai V, de Assis Rosa D, Werner L, Moodley R, Hong H, Kharsany A, Mlisana K, Sibeko S, Garrett N, Chopera D, Carr WH, Abdool Karim Q, Hill AV, Abdool Karim SS, Altfeld M, Gray CM, Ndung'u T.

BMC Infect Dis. 2016 Jan 25;16:27. doi: 10.1186/s12879-016-1361-1.

31.

Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa.

Kharsany AB, Cawood C, Khanyile D, Grobler A, Mckinnon LR, Samsunder N, Frohlich JA, Abdool Karim Q, Puren A, Welte A, George G, Govender K, Toledo C, Chipeta Z, Zembe L, Glenshaw MT, Madurai L, Deyde VM, Bere A.

BMC Public Health. 2015 Nov 20;15:1149. doi: 10.1186/s12889-015-2179-2.

32.

Tenofovir Gel to Prevent HSV-2 Infection.

Abdool Karim SS, Abdool Karim Q, Gengiah TN.

N Engl J Med. 2015 Nov 12;373(20):1980-1. doi: 10.1056/NEJMc1511338. No abstract available.

PMID:
26559584
33.

Inflammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection.

Masson L, Arnold KB, Little F, Mlisana K, Lewis DA, Mkhize N, Gamieldien H, Ngcapu S, Johnson L, Lauffenburger DA, Abdool Karim Q, Abdool Karim SS, Passmore JA.

Sex Transm Infect. 2016 May;92(3):186-93. doi: 10.1136/sextrans-2015-052072. Epub 2015 Oct 28.

PMID:
26511781
34.

Challenges with participant reimbursement: experiences from a post-trial access study.

Mngadi KT, Frohlich J, Montague C, Singh J, Nkomonde N, Mvandaba N, Ntombeka F, Luthuli L, Abdool Karim Q, Mansoor L.

J Med Ethics. 2015 Nov;41(11):909-13. doi: 10.1136/medethics-2013-101899. Epub 2015 Sep 21.

PMID:
26392172
35.

Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection.

Abdool Karim SS, Abdool Karim Q, Kharsany AB, Baxter C, Grobler AC, Werner L, Kashuba A, Mansoor LE, Samsunder N, Mindel A, Gengiah TN; CAPRISA 004 Trial Group.

N Engl J Med. 2015 Aug 6;373(6):530-9. doi: 10.1056/NEJMoa1410649.

36.

Trends in HIV Prevalence in Pregnant Women in Rural South Africa.

Kharsany AB, Frohlich JA, Yende-Zuma N, Mahlase G, Samsunder N, Dellar RC, Zuma-Mkhonza M, Abdool Karim SS, Abdool Karim Q.

J Acquir Immune Defic Syndr. 2015 Nov 1;70(3):289-95. doi: 10.1097/QAI.0000000000000761.

37.

Genital inflammation and the risk of HIV acquisition in women.

Masson L, Passmore JA, Liebenberg LJ, Werner L, Baxter C, Arnold KB, Williamson C, Little F, Mansoor LE, Naranbhai V, Lauffenburger DA, Ronacher K, Walzl G, Garrett NJ, Williams BL, Couto-Rodriguez M, Hornig M, Lipkin WI, Grobler A, Abdool Karim Q, Abdool Karim SS.

Clin Infect Dis. 2015 Jul 15;61(2):260-9. doi: 10.1093/cid/civ298. Epub 2015 Apr 21.

38.

Ability to develop broadly neutralizing HIV-1 antibodies is not restricted by the germline Ig gene repertoire.

Scheepers C, Shrestha RK, Lambson BE, Jackson KJ, Wright IA, Naicker D, Goosen M, Berrie L, Ismail A, Garrett N, Abdool Karim Q, Abdool Karim SS, Moore PL, Travers SA, Morris L.

J Immunol. 2015 May 1;194(9):4371-8. doi: 10.4049/jimmunol.1500118. Epub 2015 Mar 30.

39.

Antibodies for HIV prevention in young women.

Abdool Karim SS, Abdool Karim Q, Baxter C.

Curr Opin HIV AIDS. 2015 May;10(3):183-9. doi: 10.1097/COH.0000000000000147. Review.

40.

HIV-positive status disclosure in patients in care in rural South Africa: implications for scaling up treatment and prevention interventions.

Abdool Karim Q, Dellar RC, Bearnot B, Werner L, Frohlich JA, Kharsany AB, Abdool Karim SS.

AIDS Behav. 2015 Feb;19(2):322-9. doi: 10.1007/s10461-014-0951-4.

41.

Assessing the implementation effectiveness and safety of 1% tenofovir gel provision through family planning services in KwaZulu-Natal, South Africa: study protocol for an open-label randomized controlled trial.

Mansoor LE, Abdool Karim Q, Mngadi KT, Dlamini S, Montague C, Nkomonde N, Mvandaba N, Baxter C, Gengiah TN, Samsunder N, Dawood H, Grobler A, Frohlich JA, Abdool Karim SS.

Trials. 2014 Dec 19;15:496. doi: 10.1186/1745-6215-15-496.

42.

Low adverse event rates following voluntary medical male circumcision in a high HIV disease burden public sector prevention programme in South Africa.

Phili R, Abdool-Karim Q, Ngesa O.

J Int AIDS Soc. 2014 Nov 17;17:19275. doi: 10.7448/IAS.17.1.19275. eCollection 2014.

43.

Meeting the sexual and reproductive health needs of high-school students in South Africa: experiences from rural KwaZulu-Natal.

Frohlich JA, Mkhize N, Dellar RC, Mahlase G, Montague CT, Abdool Karim Q.

S Afr Med J. 2014 May 16;104(10):687-90. doi: 10.7196/samj.7841. Erratum in: S Afr Med J. 2015 Jan;105(1):6.

PMID:
25363055
44.

HIV disease progression in seroconvertors from the CAPRISA 004 tenofovir gel pre-exposure prophylaxis trial.

Garrett NJ, Werner L, Naicker N, Naranbhai V, Sibeko S, Samsunder N, Gray C, Williamson C, Morris L, Abdool-Karim Q, Abdool-Karim SS.

J Acquir Immune Defic Syndr. 2015 Jan 1;68(1):55-61. doi: 10.1097/QAI.0000000000000367.

45.

ARV-based HIV prevention for women - where we are in 2014.

Mastro TD, Sista N, Abdool-Karim Q.

J Int AIDS Soc. 2014 Sep 8;17(3 Suppl 2):19154. doi: 10.7448/IAS.17.3.19154. eCollection 2014. Review.

46.

Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study.

Masson L, Mlisana K, Little F, Werner L, Mkhize NN, Ronacher K, Gamieldien H, Williamson C, Mckinnon LR, Walzl G, Abdool Karim Q, Abdool Karim SS, Passmore JA.

Sex Transm Infect. 2014 Dec;90(8):580-7. doi: 10.1136/sextrans-2014-051601. Epub 2014 Aug 8.

PMID:
25107710
47.

Honing in on enteric fever.

McKinnon LR, Abdool Karim Q.

Elife. 2014 Jul 1;3:e03545. doi: 10.7554/eLife.03545.

48.

Prevalence of HIV, HSV-2 and pregnancy among high school students in rural KwaZulu-Natal, South Africa: a bio-behavioural cross-sectional survey.

Abdool Karim Q, Kharsany AB, Leask K, Ntombela F, Humphries H, Frohlich JA, Samsunder N, Grobler A, Dellar R, Abdool Karim SS.

Sex Transm Infect. 2014 Dec;90(8):620-6. doi: 10.1136/sextrans-2014-051548. Epub 2014 May 29.

49.

The preventive misconception: experiences from CAPRISA 004.

Dellar RC, Abdool Karim Q, Mansoor LE, Grobler A, Humphries H, Werner L, Ntombela F, Luthuli L, Abdool Karim SS.

AIDS Behav. 2014 Sep;18(9):1746-52. doi: 10.1007/s10461-014-0771-6.

PMID:
24715227
50.

The HIV epidemic in Southern Africa - Is an AIDS-free generation possible?

Delva W, Abdool Karim Q.

Curr HIV/AIDS Rep. 2014 Jun;11(2):99-108. doi: 10.1007/s11904-014-0205-0. Review.

PMID:
24676559

Supplemental Content

Loading ...
Support Center